Q4 FY2026 · ended Jun 30, 2026 · Revenue $100.92M, -20.9% YoY · Filed Aug 27, 2026
Accuray Inc (ARAY) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q4 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $100.9 million and a net loss of $1.9 million. Free cash flow was $2.0 million. As of Jun 30, 2026 it held $40.6 million in cash and investments and $183.9 million in total debt.
Revenue
$100.92M
-20.9% vs year-ago quarter
Net income
$-1.94M
-272.8% vs year-ago quarter
Operating cash flow
$2.43M
+125.0% vs year-ago quarter
Free cash flow
$1.97M
+117.8% vs year-ago quarter
EPS
$-0.11
-650.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
119.44M
+6.0% vs year-ago quarter
Net cash
$-143.25M
Q4 FY2026
Operating margin
5.5%
Q4 FY2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- ARAY (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Madison, WI
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1138723
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q4 FY2026 Jun 30, 2026 |
Q3 FY2026 Mar 31, 2026 |
Q2 FY2026 Dec 31, 2025 |
Q1 FY2026 Sep 30, 2025 |
Q4 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $100.9M | $104.8M | $102.2M | $93.9M | $127.5M |
| Operating income | $5.5M | -$9.1M | -$11.6M | -$11.3M | $4.2M |
| Net income | -$1.9M | -$11.8M | -$13.8M | -$21.7M | $1.1M |
| Diluted EPS | — | — | -$0.11 | -$0.18 | $0.01 |
| Operating cash flow | $2.4M | -$5.6M | -$16.0M | $12.2M | -$9.7M |
| Free cash flow | $2.0M | -$6.1M | -$19.0M | $10.3M | -$11.0M |
| Total assets | $443.7M | $447.6M | $448.0M | $456.8M | $470.2M |
| Total liabilities | $402.0M | $405.9M | $394.6M | $394.9M | $389.1M |
| Stockholders' equity | $41.7M | $41.7M | $53.4M | $61.9M | $81.2M |
| Cash and investments | $40.6M | $38.1M | $41.3M | $63.3M | $57.4M |
| Total debt | $183.9M | $182.4M | $174.2M | $192.0M | $189.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2026 | Nov 4, 2026 |
| ARS | Annual report to shareholders | Oct 16, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 13, 2026 | Oct 8, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Oct 6, 2026 | Oct 5, 2026 |
| 10-K | Annual report | Aug 27, 2026 | Jun 30, 2026 |
All 1002 Accuray Inc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.